KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to -$1.6 billion.

  • Cvs Health's Tax Provisions fell 41192.84% to -$1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $408.0 million, marking a year-over-year decrease of 7387.96%. This contributed to the annual value of $408.0 million for FY2025, which is 7387.96% down from last year.
  • Per Cvs Health's latest filing, its Tax Provisions stood at -$1.6 billion for Q4 2025, which was down 41192.84% from $508.0 million recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Tax Provisions ranged from a high of $1.1 billion in Q2 2022 and a low of -$1.6 billion during Q4 2025
  • For the 5-year period, Cvs Health's Tax Provisions averaged around $441.6 million, with its median value being $640.0 million (2022).
  • Examining YoY changes over the last 5 years, Cvs Health's Tax Provisions showed a top increase of 139411.76% in 2025 and a maximum decrease of 41192.84% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Tax Provisions stood at $300.0 million in 2021, then surged by 172.67% to $818.0 million in 2022, then dropped by 19.56% to $658.0 million in 2023, then fell by 23.56% to $503.0 million in 2024, then tumbled by 411.93% to -$1.6 billion in 2025.
  • Its last three reported values are -$1.6 billion in Q4 2025, $508.0 million for Q3 2025, and $634.0 million during Q2 2025.